NCT07576244 Effects of Core Stabilization Exercises and Myofascial Induction Therapy in Postpartum Low-back Pain
| NCT ID | NCT07576244 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Low Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-10-01 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to determine the combine effects of core stabilization exercises and Myofascial Induction therapy on lumber pain, core endurance and quality of life on postpartum low-back pain.
Eligibility Criteria
Inclusion Criteria: * Will have a NPRS scoring ranging 3-8 * Female with normal vaginal delivery (SVD) * Patients within 6 months of postpartum * BMI \< 30 kg/ m2 Exclusion Criteria: * Spinal fracture or deformity * Arthritis * Lumber radiculopathy * Inflammatory condition that cause low back pain * Severe discopathy
Contact & Investigator
hina G gul, PhD*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07576244 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 45 Years, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07576244 currently recruiting?
Yes, NCT07576244 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07576244 trial being conducted?
This trial is being conducted at Sialkot, Pakistan.
Who is sponsoring the NCT07576244 clinical trial?
NCT07576244 is sponsored by Riphah International University. The principal investigator is hina G gul, PhD* at Riphah International University. The trial plans to enroll 40 participants.